AGP Picks
View all

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on June 11, 2026

NetBox Labs 宣佈推出基建智能平台,其新功能涵蓋整個網絡及基建生命週期
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference
Staffan Canbäck intervjuad av Affärsvärlden på nationaldagen om Sveriges svaga ekonomi
Geodaka Integrates Home Improvement Network with Property Mapping System
AI Investment Surge Reaches $700 Billion as Global Competition Intensifies, New BCC Research Analysis Reveals
Lakeside Software Named as a Leader in the 2026 Gartner® Magic Quadrant™ for Digital Employee Experience Management Tools for Third Consecutive Year
IP Fabric Appoints Jonathan Korntheuer as Chief Financial Officer
NFL’s ALEX SMITH JOINS OXEIA INVESTOR WEBINAR EXPLORING WHAT COULD BECOME THE FIRST FDA-APPROVED CONCUSSION THERAPY
Parexel to Highlight Expertise Across Eight Thought Leadership Sessions at 2026 DIA Global Annual Meeting
The AREA Welcomes MultiSet AI as a Member
Salary.com Honored with 2026 BWWC Wage Equity Impact Award for Measurable Progress on Pay Equity
 ATI Engage® Honored for Advancing Digital Learning in Nursing Education
Zevra’s Chief Medical Officer to Step Down for Personal Reasons as Part of Planned Transition
Imviva Biotech Presents Studies on CTD402 Allogeneic CAR-T Therapy at EHA2026 Congress
Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer
In tomorrow’s AI economy, what’s the role of humans?
C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population
Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Massachusetts Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.